Anixa Biosciences market cap: $96.991 M

Biotechnology: Pharmaceutical Preparations, ranked by market cap

#310Neonc TechnologiesNTHI$102.7M
#311Citius OncologyCTOR$99.5M
#312Anixa BiosciencesANIX$97.0M
#313Acrivon TherapeuticsACRV$92.1M
#314Oncolytics BiotechONCY$91.0M

Insiders buying

6 open-market purchases by officers and directors of Anixa Biosciences, worth $92.0K. Grants and option exercises are excluded.

Lewis H. Titterton Jr.$27.3K
10,000 shares at $2.73 on 10 Sept 2026 · filed 14 Sept 2026
Amit KumarChief Executive Officer$8.25K
3,000 shares at $2.75 on 10 Sept 2026 · filed 14 Sept 2026
Amit KumarChief Executive Officer$17.4K
5,000 shares at $3.47 on 31 Jul 2026 · filed 3 Aug 2026
Amit KumarChief Executive Officer$17.2K
5,000 shares at $3.44 on 27 Jul 2026 · filed 28 Jul 2026
Amit KumarChief Executive Officer$11.2K
3,000 shares at $3.73 on 24 Jul 2026 · filed 27 Jul 2026
Amit KumarChief Executive Officer$10.7K
3,188 shares at $3.37 on 27 Jul 2026 · filed 27 Jul 2026

What if Anixa Biosciences were worth as much as…

Open the what-if tool →

Gold $30.2T

$869,696.86

Per share 311,719× higher

Bitcoin $1.74T

$50,099.67

Per share 17,957× higher

Nvidia $5.52T

$158,664.09

Per share 56,869× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Anixa Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.